Notice of Early Expiration of PAR-20-089 "Biomedical Data Repository (U24 - Clinical Trials Not Allowed)"
Notice Number:
NOT-GM-23-029

Key Dates

Release Date:

December 22, 2022

Related Announcements

PAR-20-089 - Biomedical Data Repository (U24 - Clinical Trials Not Allowed)

PAR-23-079 - Biomedical Data Repository (U24 - Clinical Trials Not Allowed)

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to alert potential applicants to the early expiration of PAR-20-089 "Biomedical Data Repository (U24 - Clinical Trials Not Allowed)". This FOA will expire on January 7, 2023. Applications for the January 25, 2023 and May 8, 2023 due dates must be submitted to the reissuance PAR-23-079 "Biomedical Data Repository (U24 - Clinical Trials Not Allowed)"

The FOA has been updated accordingly.

Part 1. Key Dates

The FOA currently reads:

Application Due Date(s)

September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

January 7, 2021; May 7, 2021; January 7, 2022; May 6, 2022; January 6, 2023; May 8, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Scientific Merit Review

March 2021; July 2021; March 2022; July 2022; March 2023; July 2023

Advisory Council Review

May 2021; October 2021; May 2022; October 2022; May 2023; October 2023?

Earliest Start Date

July 2021; December 2021; July 2022; December 2022; July 2023; December 2023?

Expiration Date

May 09, 2023

The FOA is modified to read:

Application Due Date(s)

September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

January 7, 2021; May 7, 2021; January 7, 2022; May 6, 2022; January 6, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Scientific Merit Review

March 2021; July 2021; March 2022; July 2022; March 2023

Advisory Council Review

May 2021; October 2021; May 2022; October 2022; May 2023

Earliest Start Date

July 2021; December 2021; July 2022; December 2022; July 2023

Expiration Date

January 7, 2023

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Jean Yuan, M.D., PhD
National Institute of General Medical Sciences
Email: [email protected]